市場調查報告書

家禽用疫苗的全球市場 - 成長,趨勢,預測(2019年∼2024年)

Poultry Vaccines Market - Growth, Trends, and Forecast (2019 - 2024)

出版商 Mordor Intelligence LLP 商品編碼 910283
出版日期 內容資訊 英文 114 Pages
商品交期: 2-3個工作天內
價格
Back to Top
家禽用疫苗的全球市場 - 成長,趨勢,預測(2019年∼2024年) Poultry Vaccines Market - Growth, Trends, and Forecast (2019 - 2024)
出版日期: 2019年09月01日內容資訊: 英文 114 Pages
簡介

飼養的家禽的增加,食品安全性的興趣高漲,人獸通用感染疾病的增加,全世界的肉類需求擴大,疫苗製造的新技術等成為這個市場主要的促進成長因素。

本報告提供全球家禽用疫苗市場調查,市場概要,各疾病、技術、地區的市場規模的變化與預測,市場成長要素及阻礙因素分析,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 簡介

  • 調查成果
  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 市場成長要素
    • 家禽疾病增加
    • 對食品安全性的興趣高漲
    • 人獸通用感染疾病的發生率增加
  • 市場阻礙因素
    • 偽造醫藥品的使用
    • 動物實驗及獸醫服務的成本增加
  • 波特的五力分析
    • 買方議價能力
    • 供給企業談判力
    • 新加入業者的威脅
    • 替代品的威脅
    • 競爭企業間的敵對關係

第5章 市場區隔

  • 各疾病
    • 支氣管炎
    • 禽流感
    • 新城病
    • 馬立克氏病
    • 其他
  • 各技術
    • 類毒素疫苗
    • 重組疫苗
    • 不活化疫苗
    • 減毒活病毒疫苗(LAV)
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • AniCon Labor GmbH
    • Animal Science Products Inc.
    • Biovac
    • Boehringer Ingelheim International GmbH
    • ADL BIONATUR SOLUTIONS, S.A.
    • Ceva Animal Health
    • Elanco
    • Intervac (Pvt) Ltd
    • Merck Animal Health
    • Merial
    • Phibro Animal Health Corporation
    • Zoetis Inc

第7章 市場機會及未來趨勢

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 57307

Market Overview

The demand for poultry vaccines is majorly driven by the growing poultry headcount and increasing prevalence of zoonotic diseases in poultry. Furthermore, growing consumption of meat globally, initiatives are taken by the government, growing demand for poultry-related food products, latest technologies for manufacturing new vaccines and the increasing poultry healthcare expenditure are the factors that are fueling the growth of the global poultry vaccines market.

Scope of the Report

Vaccines help to prevent any particular disease by boosting the bird's immune system to produce antibodies, which in turn, fight against organisms, especially Salmonella, E. coli, and Mycoplasma gallisepticum (MG), and diseases like Marek's disease, infectious bronchitis (IB), avian rhinotracheitis (ART), Newcastle disease, and infectious bursal disease (Gumboro disease).

Key Market Trends

Avian influenza is Expected to Lead the Market

Avian influenza is a viral disease which is found across all the countries in the world and occurs in birds. The severity of the disease can vary from mild to severe. Avian influenza is transmitted to human beings by direct contact. Disease outbreaks have been reported in countries, such as the United States, Asia, and Europe. The vaccines are approved only if they pass the standards set by the World Organization for Animal Health. The vaccine for the avian influenza is given to imbibe the protection against hemagglutinin (HA) protein. The CDC has given statistics on the spread of avian influenza in the United States. The stats indicate that HPAI H5 viruses were reported in around 21 states in the United States during 2014-2015. Furthermore, the CDC has reported that the mortality for this disease is around 90%-100%. This shows that the disease is associated with a high risk. Hence, the regulatory bodies are now accelerating the process of approval for various vaccines related to veterinary health.

North America is expected to dominate over the Forecast Period

North America is expected to dominate the market over the forecast period, owing to the factors, such as the increase in consumption of poultry-derived products, growing consumer awareness regarding food safety, and increasing incidence of zoonotic diseases associated with poultry. According to the data published by the US department of agriculture (USDA), the per capita consumption of poultry products in 2016 was 107.6 pounds and was increased to 108.6 pounds in 2017. Furthermore, there is an increase in the production of eggs and hen, in shell in the region, as per the statistics published by the UNFAO. In 2015, the country produced 14,639,012 ton of eggs, hen, in shell, which was increased to 14,490,724 ton in 2016. Veterinary Vaccines in the United States is regulated by the Center for Veterinary Biologics (CVB) in the Animal and Plant Health Inspection Service (APHIS). The CVB grants establishment and product license to animal health companies, to manufacture and sell veterinary biologics. In North America advancements in vaccines development include the development of live vector vaccines, non-replicating recombinant antigen vaccines, nucleic acid-mediated vaccines, and live-gene-deleted vaccines.

Competitive Landscape

The market players in the poultry vaccines market are involving in various growth strategies such as collaborations, partnerships, agreements, mergers, and acquisitions in order to enhance the market presence. Key players in the market are Merial, AniCon Labor GmbH, Animal Science Products, Inc., Bio-Vet, Boehringer Ingelheim, Ceva Animal Health, Elanco, Intervac (Pvt) Ltd, Merck & Co., Phibro Animal Health Corporation, Seppic, Venkys, and Zoetis Inc.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Incidences of Poultry Diseases
    • 4.2.2 Widened Focus on Food Safety
    • 4.2.3 Increasing Incidences of Zoonotic Diseases
  • 4.3 Market Restraints
    • 4.3.1 Use of Counterfeit Medicine
    • 4.3.2 Increasing Costs of Animal Testing and Veterinary Services
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Disease
    • 5.1.1 Bronchitis
    • 5.1.2 Avian Influenza
    • 5.1.3 Newcastle disease
    • 5.1.4 Marek's Disease
    • 5.1.5 Others
  • 5.2 By Technology
    • 5.2.1 Toxoid Vaccines
    • 5.2.2 Recombinant Vaccines
    • 5.2.3 Inactivated Vaccines
    • 5.2.4 Live Attenuated Vaccines (LAV)
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 US
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 UK
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 AniCon Labor GmbH
    • 6.1.2 Animal Science Products Inc.
    • 6.1.3 Biovac
    • 6.1.4 Boehringer Ingelheim International GmbH
    • 6.1.5 ADL BIONATUR SOLUTIONS, S.A.
    • 6.1.6 Ceva Animal Health
    • 6.1.7 Elanco
    • 6.1.8 Intervac (Pvt) Ltd
    • 6.1.9 Merck Animal Health
    • 6.1.10 Merial
    • 6.1.11 Phibro Animal Health Corporation
    • 6.1.12 Zoetis Inc

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top